JUNE 10, 2021, Vancouver, British Columbia: wellteq Digital Health Inc. (CSE:WTEQ) (OTC:WTEQF), (the “Company” or “wellteq”), is pleased to announce the Company has signed a letter of intent (the “LOI”) detailing the general terms of a strategic partnership with CANImmunize Inc., an Ottawa-based technology company specializing in immunization software solutions. The strategic partnership will create varied offerings incorporating digital vaccination records and enterprise wellness for a variety of corporate customers initially across Canada and Asia Pacific, then more broadly.
Due to COVID-19, countries and organizations are facing immediate challenges in creating immunization information systems that can effectively and accurately track vaccinations. The return to normal activities and the migration of people across regional and national borders and the increasingly fragmented nature of immunization practice with individuals receiving information from multiple different providers are major obstacles to having comprehensive immunization status.
The CANImmunize team has over a decade of experience developing digital immunization solutions for businesses, health care organizations and governments, including COVID-19 vaccination software. CANImmunize has developed the internationally recognized CANImmunize app, a pan-Canadian digital immunization tracking system that helps Canadians keep track of their vaccinations with a mobile app and web portal. Users of the CANImmunize app can see their immunization records, get accurate information on vaccinations, receive reminders about immunizations and alerts about vaccine-preventable diseases. The app is recognized by the European Centre for Disease Prevention and Control as a model for consumer facing immunization solutions and canimmunize.ca is certified by the WHO VaccineSafetyNet.
“CANImmunize is excited to collaborate with Wellteq on this strategic partnership,” stated Dr. Kumanan Wilson, CEO of CANImmunize and a physician-researcher at The Ottawa Hospital. “The COVID-19 pandemic has underscored the importance of keeping employees safe and healthy. We look forward to combining our 10 years’ experience in developing immunization solutions with wellteq’s expertise to ensure the well-being of employees.”
Scott Montgomery, CEO of wellteq, stated, “The days of prescribing pills as the default form of healthcare are coming to an end. The transformation of healthcare to being more proactive and preventive is here, it’s happening now. By offering vaccination records seamlessly alongside wellness coaching, we offer employers and insurers the best proactive and preventive healthcare available.
CANImmunize is a science-based technology company specializing in immunization software. The team has over 10 years’ experience developing digital immunization solutions for businesses, health care organizations and governments, including COVID-19 vaccination software, tracking and other immunization needs. It developed the internationally-recognized CANImmunize app, a pan-Canadian digital immunization tracking system that helps Canadians keep track of their vaccinations with a mobile app and web portal.
wellteq Digital Health Inc. is a leading global provider of personalized digital health and wellness
solutions across the continuum of care.
To learn more, visit https://wellteq.co/
Download the wellteq Corporate Presentation:
wellteq Investor Contact:
Bristol Investor Relations
T: (905) 326-1888z
Cautionary Note Regarding Forward-Looking Statements:
This news release contains information or statements that constitute “forward-looking statements.” Such forward looking statements
involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or
developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forwardlooking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified
by words such as “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “potential” and similar expressions, or
that events or conditions “will,” “would,” “may,” “could” or “should” occur.
Forward looking information may include, without limitation, statements regarding the operations, business, financial condition, expected
financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of
Wellteq, and includes statements about, among other things, future developments and the future operations, strengths and strategies of
Wellteq. Forward-looking information is provided for the purpose of presenting information about management’s current expectations
and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. These
statements should not be read as guarantees of future performance or results.
The forward-looking statements made in this news release are based on management’s assumptions and analysis and other factors that
may be drawn upon by management to form conclusions and make forecasts or projections, including management’s experience and
assessments of historical trends, current conditions and expected future developments. Although management believes that these
assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results
may differ materially from those projected in any forward-looking statements. Examples of risks and factors that could cause actual
results to materially differ from forward-looking statements may include: the timing and unpredictability of regulatory actions; regulatory,
legislative, legal or other developments with respect to its operations or business; limited marketing and sales capabilities; early stage of
the industry and product development; limited products; reliance on third parties; unfavourable publicity or consumer perception; general
economic conditions and financial markets; the impact of increasing competition; the loss of key management personnel; capital
requirements and liquidity; access to capital; the timing and amount of capital expenditures; the impact of COVID-19; shifts in the demand
for Wellteq’s products and the size of the market; patent law reform; patent litigation and intellectual property; conflicts of interest; and
general market and economic conditions.
The forward-looking information contained in this news release represents the expectations of Wellteq as of the date of this news release
and, accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and
should not rely upon this information as of any other date. Wellteq undertakes no obligation to update these forward-looking statements
in the event that management’s beliefs, estimates or opinions, or other factors, should change.
The CSE has neither approved nor disapproved the contents of this news release.